The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

February 28, 2003

Study Completion Date

October 31, 2005

Conditions
Heart Failure, CongestiveDyspneaPulmonary Edema
Interventions
DRUG

ALT-711

Trial Locations (2)

27157-1045

Wake Forest University Baptist Medical Center, Department of Cardiology, Winston-Salem

29425 and 29401

Medical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston

All Listed Sponsors
lead

Synvista Therapeutics, Inc

INDUSTRY

NCT00043836 - The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure | Biotech Hunter | Biotech Hunter